Globe Life Inc (GL)

Globe Life Inc. is a U.S.-based insurance company listed on the NYSE under the ticker GL. Through its subsidiaries, the company provides life and supplemental health insurance products primarily to lower middle- and middle-income families across the United States. Its operations are organized into three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company’s insurance portfolio includes whole life, term life, children’s life insurance, Medicare supplement coverage, and limited-benefit supplemental health products such as accident, cancer, critical illness, heart, intensive care, and other related coverages. Globe Life also writes final expense, accidental death, mortgage protection, and hospital insurance. Distribution is carried out through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. Founded in 1900 and headquartered in McKinney, Texas, the company was previously known as Torchmark Corporation before adopting its current name in August 2019.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-GL
$168.01
-8.7% Downside
Fair
$188.55
2.4% Upside
Fair
Great
July 6, 2026
July 31, 2026
1.32
0.7%
July 22, 2026
12.1x
2.3x
2.4x
14.306 B
17.28 B
18.6%
99.1%
1.3
7.4%
104.5%
Valuation • Fair Value

Globe Life Inc (NYSE-GL) Fair Value by Valuation Model

Compare the primary fair value estimate for Globe Life Inc (NYSE-GL) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$168.01

Estimated downside of 8.7% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$168.23

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$168.01

Comparable-company valuation reference.

Analyst Price Target

$188.55

Analysts imply upside of 2.4%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Globe Life Inc (NYSE-GL) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Globe Life Inc (NYSE-GL)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

6.074 B

Current operating scale indicator.

Revenue Forecast

6.406 B

Forward revenue estimate.

EBITDA

1.638 B

Current operating profitability reference.

EBITDA Forecast

1.708 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Globe Life Inc (NYSE-GL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Globe Life Inc (NYSE-GL)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

1.3

Lower score that deserves closer risk review.

FCF / Net Income

104.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Globe Life Inc (NYSE-GL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Globe Life Inc (NYSE-GL)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 22, 2026

Days to Earnings

1

Dividend Payment Date

July 31, 2026

Ex-Dividend Date

July 6, 2026

Dividend Yield

0.7%

Income yield reference.

Upcoming Dividend

1.32

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

7.4%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Globe Life Inc (NYSE-GL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Globe Life Inc (NYSE-GL) Stock Forecast & Technical Outlook

Review Globe Life Inc (NYSE-GL) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Globe Life Inc (NYSE-GL) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Globe Life Inc (NYSE-GL) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Globe Life Inc (NYSE-GL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Globe Life Inc (NYSE-GL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Globe Life Inc (NYSE-GL) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Globe Life Inc (NYSE-GL)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Globe Life Inc (NYSE-GL) has a Buy consensus, with 4 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 3
Sell 0
FAQ Fast Investor Answers

Globe Life Inc (NYSE-GL) Stock FAQ

Quick answers about Globe Life Inc (NYSE-GL) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$168.01
Estimated downside 8.7%
Valuation Rating
Overvalued
Estimated downside of 8.7%
Analyst Target
$188.55
Implied upside 2.4%
Financial Health
Great
Current financial-health read

The current fair value estimate for Globe Life Inc (NYSE-GL) is $168.01. This implies an estimated downside of 8.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 8.7% versus the current market price.

The available analyst price target for Globe Life Inc (NYSE-GL) is $188.55. The analyst target implies estimated upside of 2.4%.

The current financial health read for Globe Life Inc (NYSE-GL) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Globe Life Inc (NYSE-GL) is July 22, 2026.

Based on the current data, dividend yield is 0.7%, upcoming dividend amount is 1.32, ex-dividend date is July 6, 2026, payment date is July 31, 2026.

The current P/E ratio listed for Globe Life Inc (NYSE-GL) is 12.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Globe Life Inc is 14.306 B.

The current enterprise value listed for Globe Life Inc is 17.28 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Globe Life Inc is NYSE-GL, and the stock is listed on NYSE.

Globe Life Inc (NYSE-GL) is listed on NYSE.

The current debt-to-total-capital ratio listed for Globe Life Inc is 18.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Globe Life Inc is 99.1%. Free float helps investors understand how much of the share base is available for public trading.